跳至主要内容
临床试验/CTRI/2024/12/078062
CTRI/2024/12/078062尚未招募不适用

Pulse pressure variation guided goal-directed fluid therapy versus liberal fluid therapy in adult patients undergoing major emergency surgery: A randomized controlled trial

AIIMS Kalyani1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2024年12月21日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
AIIMS Kalyani
入组人数
62
试验地点
1
主要终点
Sequential Organ Failure

研究概览

简要总结

Background: Optimal intraoperative fluid management significantly improves postoperative outcomes, particularly in major surgeries. Fluid management in emergency surgeries is more challenging than in elective settings as mortality risk is approximately eightfold higher.  Widely used liberal fluid therapy (LFT), can lead to complications like fluid overload. Goal-directed fluid therapy (GDFT) is effective but often invasive and costly. Pulse Pressure Variation (PPV)-guided GDFT offers a minimally invasive and cost-effective alternative with the potential to reduce postoperative complications.

Objective: This study aims to compare the impact of intraoperative PPV-guided GDFT with conventional LFT on postoperative outcomes in adult patients undergoing major emergency surgeries.

Methods:

This single-centre, randomized, controlled, triple-blind, parallel-arm trial will be conducted at AIIMS Kalyani. A total of 62 patients will be randomly assigned to two groups (PPV-GDFT or LFT) in a 1:1 ratio using a computer-generated randomization table. Allocation will be concealed using sequentially numbered, sealed envelopes.

Inclusion criteria: Adults (18–65 years), ASA grades I–IV, undergoing emergency major surgeries under general anaesthesia.

Exclusion criteria: Patients presenting with bleeding emergencies requiring immediate life-saving surgical intervention, resuscitative laparotomy, ED thoracotomy, post-cardiac arrest status, Neurological emergency, Pregnancy, burn injuries, ASA V category, acute liver failure, Known coagulopathy or on anticoagulant therapy (unmanageable in a perioperative setting), Pre-existing severe cardiac dysfunction (ejection fraction <30%, severe cardiac arrhythmia, severe valvular disease, intracardiac shunt) and  Patients with terminal cancer needing palliative surgery or receiving regular renal replacement therapy.

Intervention:

LFT group: Balanced crystalloid (Plasmalyte) based on the Holliday–Segar formula, with adjustments for cumulative losses, blood loss, and urine output.

PPV-GDFT group: Balanced crystalloid to maintain PPV

12%.

In both groups, mean arterial pressure (MAP) >70 mmHg and urine output >0.5 mL/kg/hr will be maintained, with vasopressors administered if necessary.

Postoperative management will include maintaining urine output >0.5 mL/kg/hr and MAP >70 mmHg until patients resume oral intake. Excessive fluid balance (>1 L) will be managed with furosemide.

 Outcomes:

Primary outcome: Postoperative Sequential Organ Failure Assessment (SOFA) scores on days 1, 2, and 5.

Secondary outcomes: Intraoperative fluid balance, hypotension episodes, vasopressor use, postoperative serum lactate, serum albumin, C-reactive protein, complications (surgical/non-surgical), length of hospital stay, and mortality.

Statistical Analysis:

Data will be collected using a paper-based case report form and entered into Excel. Continuous data will be analyzed using Mann–Whitney or Student’s t-tests, and categorical data with Fisher’s exact test. Statistical significance will be set at P < 0.05.

Conclusion: This trial will assess whether PPV-guided GDFT provides superior outcomes compared to conventional LFT in major emergency surgeries.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • ASA (American Society of Anesthesiologists) physical status I-IV Major emergency surgery (including abdominal, thoracic, and pelvic surgery)- for example, surgery for Gastrointestinal perforation/ obstruction, obstructed hernia, appendicitis/Cholecystitis with sepsis/localised peritonitis, abdominal sepsis, Fournier/Maloney gangrene, necrotising fasciitis, penetrating/blunt trauma abdomen with solid organ injury or hollow viscera injury, Necrotising hemorrhagic pancreatitis, Thoracic empyema/ fungal infections, thoracic trauma, bronchopleural fistula grade II-IV air leak, Liver abscess, etc.

排除标准

  • 未提供

结局指标

主要结局

Sequential Organ Failure

时间窗: preoperative | postoperative- day1, day 3 and day 5

Assessment (SOFA) score

时间窗: preoperative | postoperative- day1, day 3 and day 5

次要结局

  • serum lactate:(preoperative, end of surgery or extubation and at first, second and fifth day)
  • Serum albumin:(preoperative, first, second and fifth day)
  • C-reactive protein:(preoperative, first, second fifth day)
  • fluid balance, hypotension episode and vasopressor usage(intraoperative period)
  • Post-operative surgery-related complications, pulmonary, renal, cardiovascular and haematological complications and postoperative infection.(postoperative period)
  • All-cause mortality during the longest follow-up period.
  • Length of hospital stay (hospital LOS) in days(postoperative)
  • Vasopressor or inotrope administration during the longest follow-up period to correct haemodynamic instability(postoperative)

研究者

发起方
AIIMS Kalyani
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Roshan Andleeb

AIIMS Kalyani

研究点 (1)

Loading locations...

相似试验